Grindr expands beyond dating with $250 million PurposeMed acquisition
Grindr is acquiring telehealth provider PurposeMed for $250 million to expand its healthcare services. The move aims to integrate pharmacy and clinical care into the dating platform's ecosystem to create a new, high-margin revenue stream.
Why it matters
This marks a significant pivot for a social platform into the specialized healthcare sector, potentially setting a precedent for niche apps to monetize user communities through essential services.
Grindr announced on Wednesday that it is expanding further into health care with the acquisition of PurposeMed, the parent company of HIV prevention telehealth provider Freddie, in a deal worth $250 million.
The LGBTQ-focused dating platform will pay $190 million in cash and $60 million in Grindr common stock, according to the terms of the agreement. The agreement also includes up to $70 million in additional cash consideration tied to Freddie's performance in 2027, payable in 2028. The acquisition is expected to close in the fourth quarter.
The deal is Grindr's first major acquisition since the company was founded in 2009.
"Now we have the next business line that we believe will be as profitable as the core business, and the same size, if not bigger, than what the core business is today," said CEO George Arison in an interview with CNBC.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in